These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18379834)

  • 21. Etanercept therapy in patients with advanced primary amyloidosis.
    Hussein MA; Juturi JV; Rybicki L; Lutton S; Murphy BR; Karam MA
    Med Oncol; 2003; 20(3):283-90. PubMed ID: 14514978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy.
    Mpofu S; Teh LS; Smith PJ; Moots RJ; Hawkins PN
    Rheumatology (Oxford); 2003 Feb; 42(2):362-6. PubMed ID: 12595637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
    de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
    Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AA amyloidosis complicating the hereditary periodic fever syndromes.
    Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia.
    Almoallim H; Jali I; Wali G
    Joint Bone Spine; 2013 Jul; 80(4):426-8. PubMed ID: 23453475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tenth International Symposium on Amyloid and Amyloidosis].
    Magy N; Grateau G
    Rev Med Interne; 2005 Feb; 26(2):167-71. PubMed ID: 15770789
    [No Abstract]   [Full Text] [Related]  

  • 27. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease.
    Serratrice J; Granel B; Disdier P; Weiller PJ; Dussol B
    Am J Med; 2003 Nov; 115(7):589-90. PubMed ID: 14599647
    [No Abstract]   [Full Text] [Related]  

  • 28. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Kumon Y; Hirata S; Takaoka H
    Clin Exp Rheumatol; 2014; 32(4):501-8. PubMed ID: 24959698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab.
    Kuroda T; Otaki Y; Sato H; Fujimura T; Nakatsue T; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Rheumatol Int; 2008 Sep; 28(11):1155-9. PubMed ID: 18496698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. French practical guidelines for the diagnosis and management of AA amyloidosis.
    Georgin-Lavialle S; Savey L; Buob D; Bastard JP; Fellahi S; Karras A; Boffa JJ; Grateau G; ; Audard V; Bridoux F; Damade R; Deshayes S; Giurgea I; Granel B; Hachulla E; Hot A; Jaccard A; Knebelmann B; Marciano S; Pelcot F; Sarrabay G; Boursier G; Sellam J; Terre A; Bourguiba R
    Rev Med Interne; 2023 Feb; 44(2):62-71. PubMed ID: 36759076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
    Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
    Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.
    Kluve-Beckerman B; Hardwick J; Du L; Benson MD; Monia BP; Watt A; Crooke RM; Mullick A
    Amyloid; 2011 Sep; 18(3):136-46. PubMed ID: 21830877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
    Saougou I; Markatseli TE; Papagoras C; Voulgari PV; Alamanos Y; Drosos AA
    Semin Arthritis Rheum; 2011 Apr; 40(5):398-406. PubMed ID: 20843542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.
    Aróstegui JI; Solís P; Aldea A; Cantero T; Rius J; Bahíllo P; Plaza S; Vives J; Gómez S; Yagüe J
    Eur J Pediatr; 2005 Jan; 164(1):13-6. PubMed ID: 15549379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psoriatic arthritis and etanercept].
    Pedraz J; Daudén E
    Actas Dermosifiliogr; 2010 May; 101 Suppl 1():26-34. PubMed ID: 20492877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
    Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
    Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist.
    Wong VK; Lebwohl MG
    Expert Opin Biol Ther; 2005 Nov; 5(11):1505-13. PubMed ID: 16255653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.